Commentary
The American Gastroenterological Association assembled a multidisciplinary panel of experts to develop a Clinical Care Pathway providing explicit guidance on the screening, diagnosis, and treatment of NAFLD.
This article describes the NAFLD Clinical Care Pathway they developed and provides a rationale supporting proposed steps to assist clinicians in diagnosing and managing NAFLD.
Previous Post
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
Next Post
Parsing the role of PPARs in macrophage processes